Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)-Reference-Cited by-同舟云学术

Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)

Published:2021-11 Issue: Volume:159 Page:107-112
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Butzner Michael^ORCID,Maron Martin,Sarocco Phil,Rowin Ethan,Teng Chia-Chen,Tan Hiangkiat,Stanek Eric,Robertson Laura

Funder

Cytokinetics

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Ommen;Circulation,2020

2. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study;Maron;Am J Cardiol,1994

3. New perspectives on the prevalence of hypertrophic cardiomyopathy;Semsarian;J Am Coll Cardiol,2015

4. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies;Maron;J Am Coll Cardiol,2015

5. Genetics and genomics of single-gene cardiovascular diseases: common hereditary cardiomyopathies as prototypes of single-gene disorders;Marian;J Am Coll Cardiol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data;American Journal of Cardiovascular Drugs;2024-08-22

2. An evidence review and gap analysis for obstructive hypertrophic cardiomyopathy;BMC Cardiovascular Disorders;2024-08-10

3. The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development;Journal of Medical Economics;2024-07

4. Treatment pathways defined as the sequence of visits to the public health system of patients with cardiomyopathies in Poland in the period 2016–2021;Polish Heart Journal;2024-05-31

5. Incidence and prevalence of cardiomyopathies in Poland and outcomes for patients in the years 2016–2020;Polish Heart Journal;2024-02-29